Real-world data confirm benefits of ticagrelor in ACS

A prospective study of more than 45,000 patients with acute coronary syndromes has shown that the risk of death or readmission with myocardial infarction or stroke is 15% lower with ticagrelor than with clopidogrel.
Source: MedWire News - Category: Consumer Health News Tags: Acute coronary syndromes Source Type: news